Nonalcoholic fatty liver disease: Disease and comorbidity-effects on quality of life

Nature Reviews Gastroenterology and Hepatology

Volumn 6, Issue 9, 2009, Pages 504-506

  Marchesini, Giulio ^a   Bianchi, Giampaolo ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARDIOVASCULAR DISEASE; COMORBIDITY; DIABETES MELLITUS; DISEASE SEVERITY; FATIGUE; HEALTH STATUS; HEALTH SURVEY; HUMAN; LIVER CIRRHOSIS; LIVER FIBROSIS; MENTAL HEALTH; MORTALITY; NONALCOHOLIC FATTY LIVER; OBESITY; PRIORITY JOURNAL; QUALITY OF LIFE; SHORT FORM 36;

FATIGUE; FATTY LIVER; HEALTH SURVEYS; HUMANS; METABOLIC SYNDROME X; OBESITY; QUALITY OF LIFE;

EID: 69949099142     PISSN: 17595045     EISSN: 17595053     Source Type: Journal    
DOI: 10.1038/nrgastro.2009.142     Document Type: Article

References (10)

1. Ekstedt, M. et al. Long-term follow-up of patients with nAFLD and elevated liver enzymes. Hepatology 44, 865-873 (2006).
2. Marchesini, G. et al. nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 37, 917-923 (2003).
3. David, K. et al. Quality of life in adults with nonalcoholic fatty liver disease: Baseline data from the nonalcoholic steatohepatitis clinical research network. Hepatology 49, 1904-1912 (2009).
4. ware, J. e. Jr, snow, K., Kosinski, M. & Gandek, B. SF-36 Health Survey Manual and Interpretation Guide (new england Medical Center, Boston, 1993).
5. Corica, F. et al. Construct validity of the short Form-36 Health survey and its relationship with BMi in obese outpatients. Obesity (Silver Spring) 14, 1429-1437 (2006).
6. Anderson, R. M., Fitzgerald, J. T., wisdom, K., Davis, w. K. & Hiss, R. G. A comparison of global versus disease-specific quality-of-life measures in patients with niDDM. Diabetes Care 20, 299-305 (1997).
7. Marchesini, G. et al. Factors associated with poor health-related quality of life of patients with cirrhosis. Gastroenterology 120, 170-178 (2001).
8. Helbling, B. et al. Host- rather than virus-related factors reduce health-related quality of life in hepatitis C virus infection. Gut 57, 1597-1603 (2008).
9. newton, J. L. et al. Fatigue in non-alcoholic fatty liver disease (nAFLD) is significant and associates with inactivity and excessive daytime sleepiness but not with liver disease severity or insulin resistance. Gut 57, 807-813 (2008).
10. Dan, A. A. et al. Health-related quality of life in patients with non-alcoholic fatty liver disease. Aliment. Pharmacol. Ther. 26 815-820 (2007).